Fatty liver disease (MASLD/MASH) trials in Norway

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  Where

  Oslo, Tromsø

  Age

  18 years and over

  People

  4,500 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07165028 · EU 2025-522674-36-00
• No phaseNot yet taking people in Norway
  Detecting Liver Fibrosis in Patients At-risk

  Where

  Stavanger

  Age

  40 years to 70 years

  People

  1,200

  Run by

  Helse Stavanger HF

  See details and how to joinNCT07775638